| Breast cancer: current developments in molecular approaches to diagnosis and treatment JA de la Mare, L Contu, M C Hunter, B Moyo, J N Sterrenberg, ... Recent Patents on Anti-Cancer Drug Discovery 9 (2), 153-175, 2014 | 75 | 2014 |
| AAV-mediated expression of broadly neutralizing and vaccine-like antibodies targeting the HIV-1 envelope V2 region FT van den Berg, NA Makoah, SA Ali, TA Scott, RE Mapengo, ... Molecular Therapy Methods & Clinical Development 14, 100-112, 2019 | 40 | 2019 |
| A pentavalent Epstein-Barr virus-like particle vaccine elicits high titers of neutralizing antibodies against Epstein-Barr virus infection in immunized rabbits GM Escalante, J Foley, LZ Mutsvunguma, E Rodriguez, DH Mulama, ... Vaccines 8 (2), 169, 2020 | 31 | 2020 |
| A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits DH Mulama, LZ Mutsvunguma, J Totonchy, P Ye, J Foley, GM Escalante, ... Vaccine 37 (30), 4184-4194, 2019 | 31 | 2019 |
| Four decades of prophylactic EBV vaccine research: a systematic review and historical perspective GM Escalante, LZ Mutsvunguma, M Muniraju, E Rodriguez, JG Ogembo Frontiers in Immunology 13, 867918, 2022 | 28 | 2022 |
| Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents … LZ Mutsvunguma, E Rodriguez, GM Escalante, M Muniraju, JC Williams, ... Virology 536, 1-15, 2019 | 26 | 2019 |
| Kaposi sarcoma-associated herpesvirus glycoprotein H is indispensable for infection of epithelial, endothelial, and fibroblast cell types M Muniraju, LZ Mutsvunguma, J Foley, GM Escalante, E Rodriguez, ... Journal of Virology 93 (16), 10.1128/jvi. 00630-19, 2019 | 21 | 2019 |
| Theiler’s murine encephalomyelitis virus infection induces a redistribution of heat shock proteins 70 and 90 in BHK-21 cells, and is inhibited by novobiocin and geldanamycin LZ Mutsvunguma, B Moetlhoa, AL Edkins, GA Luke, GL Blatch, C Knox Cell stress and Chaperones 16 (5), 505-515, 2011 | 12 | 2011 |
| Localisation of Theiler's murine encephalomyelitis virus protein 2C to the golgi apparatus using antibodies generated against a peptide region T Jauka, L Mutsvunguma, A Boshoff, AL Edkins, C Knox Journal of virological methods 168 (1-2), 162-169, 2010 | 8 | 2010 |
| HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study CD Warden, P Cholli, H Qin, C Guo, Y Wang, C Kancharla, AM Russell, ... Infectious Agents and Cancer 17 (1), 44, 2022 | 2 | 2022 |
| Identification of a Novel Neutralizing and Two Non-Neutralizing Epitopes on Epstein-Barr Virus gp350 Protein LZ Mutsvunguma, A Barasa, C Warden, J Foley, M Muniraju, DH Mulama, ... bioRxiv, 302844, 2018 | 2 | 2018 |
| Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice GM Escalante, IG Reidel, LZ Mutsvunguma, S Cua, BA Tello, E Rodriguez, ... Frontiers in immunology 15, 1445209, 2024 | 1 | 2024 |
| Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo M Muniraju, LZ Mutsvunguma, IG Reidel, GM Escalante, S Cua, ... Journal of Virology 98 (6), e00576-24, 2024 | 1 | 2024 |
| Multivalent epstein-barr virus-like particles and uses thereof JG Ogembo, LZ Mutsvunguma, F Wussow US Patent App. 18/612,771, 2024 | | 2024 |
| A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry S Cua, BA Tello, MA Farelo, E Rodriguez, GM Escalante, ... Viruses 16 (10), 1628, 2024 | | 2024 |
| Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study CD Warden, P Cholli, H Qin, C Guo, Y Wang, C Kancharla, AM Russell, ... Infectious Agents and Cancer 19, 28, 2024 | | 2024 |
| Epstein-Barr virus antibodies and uses thereof JG Ogembo, LZ Mutsvunguma US Patent 12,012,446, 2024 | | 2024 |
| Multivalent Epstein-Barr virus-like particles and uses thereof JG Ogembo, LZ Mutsvunguma, F Wussow US Patent 11,964,006, 2024 | | 2024 |
| Epstein-barr virus antibodies and uses thereof JG Ogembo, LZ Mutsvunguma, AE Ondrus US Patent App. 17/816,188, 2023 | | 2023 |
| Epstein-Barr virus antibodies and uses thereof JG Ogembo, LZ Mutsvunguma, AE Ondrus US Patent 11,401,323, 2022 | | 2022 |
